amantadine has been researched along with ursodeoxycholic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Perrillo, RP; Younossi, ZM | 1 |
| Shiffman, ML | 1 |
| Joo, SS; Lee, DI | 1 |
| Attia, M; Badran, HM; Barakat, E; El-Nakeeb, A; El-Tawil, A; El-Zayadi, AR; Saied, A; Selim, O; Zalata, K | 1 |
3 review(s) available for amantadine and ursodeoxycholic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The roles of amantadine, rimantadine, ursodeoxycholic acid, and NSAIDs, alone or in combination with alpha interferons, in the treatment of chronic hepatitis C.
Topics: Amantadine; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Cholagogues and Choleretics; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Rimantadine; RNA, Viral; Treatment Outcome; Ursodeoxycholic Acid | 1999 |
Management of interferon therapy nonresponders.
Topics: Alanine Transaminase; Amantadine; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Interleukin-10; Ribavirin; RNA, Viral; Ursodeoxycholic Acid | 2001 |
1 trial(s) available for amantadine and ursodeoxycholic acid
| Article | Year |
|---|---|
Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy.
Topics: Alanine Transaminase; Amantadine; Antiviral Agents; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Liver; Male; Middle Aged; Necrosis; Protective Agents; Ribavirin; RNA, Viral; Silymarin; Treatment Outcome; Ursodeoxycholic Acid | 2005 |
3 other study(ies) available for amantadine and ursodeoxycholic acid
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
The potential anti-hBV effect of amantadine in combination with ursodeoxycholic acid and biphenyl dimethyl dicarboxylate in hepG2 2.2.15 cells.
Topics: Amantadine; Antiviral Agents; Blotting, Western; Cell Line, Tumor; Dioxoles; DNA, Viral; Drug Synergism; Gene Expression; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Interferon-Stimulated Gene Factor 3; Mitochondrial Proteins; Nitric Oxide; Proteins; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Transcription Factors; Transfection; Ursodeoxycholic Acid; Virus Replication | 2005 |